Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Van King, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01142609
First received: June 10, 2010
Last updated: April 2, 2013
Last verified: April 2013

June 10, 2010
April 2, 2013
December 2009
August 2012   (final data collection date for primary outcome measure)
  • Counseling efficacy [ Time Frame: Weekly for 12 weeks ] [ Designated as safety issue: No ]
    Attendance to individual counseling sessions, both online and on-site will be tracked weekly for the duration of the study.
  • Reinforcement value (eGetgoing) [ Time Frame: Monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects will complete monthly surveys to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).
  • Reinforcement value (on-site) [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Subjects will complete a survey to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).
Same as current
Complete list of historical versions of study NCT01142609 on ClinicalTrials.gov Archive Site
  • Program Satisfaction [ Time Frame: Baseline and monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects will complete a survey to assess their overall program satisfaction
  • Treatment cost [ Time Frame: Baseline and Month 3 ] [ Designated as safety issue: No ]
    Subjects will complete surveys to measure treatment related time and monetary travel costs.
  • Therapeutic relationship [ Time Frame: Baseline and monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects and their therapists will complete surveys to assess qualities of the therapeutic relationship.
Same as current
Not Provided
Not Provided
 
Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing
Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

This research is being done to compare the effectiveness of standard on-site, in-person counseling with Internet web-based videoconferencing (e-therapy) in drug-dependent patients in opioid-agonist treatment programs. The study is looking to see if there are any differences in satisfaction or in treatment outcome if counseling sessions are given by e-therapy compared to standard, in-person counseling given in the clinic. The e-therapy happens in real time- it works very much like standard therapy in the clinic except that the patient is in his or her own home (or other convenient location outside the clinic) and talks to and sees the therapist through an Internet connection on the computer (the therapist will usually be at the clinic).

This study will be the first to evaluate the efficacy of an accredited and currently available, Internet web-based videoconferencing platform to deliver routine schedules of counseling in an opioid agonist treatment program. It has outstanding potential to help determine transportability of this technology to other treatment programs by demonstrating the benefits of integration of web-based therapy with on-site services to expand the continuum of care.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Substance Abuse Disorder
Behavioral: eGet
eGet individual counseling sessions from home will be scheduled weekly for 12 weeks.
  • Experimental: Internet (eGetgoing)
    Subjects will assigned to use an accredited web-based platform (eGetgoingTM, CRC Health Group, Inc.) to deliver routine substance abuse counseling.
    Intervention: Behavioral: eGet
  • No Intervention: Routine on-site
    Subjects will attend routine face-to-face individual counseling sessions.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
85
August 2012
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Access to a computer with Internet capability
  • Full adherence to their routine counseling schedule over the previous 30-days
  • Negative urine specimens over the previous 30-days
  • Patient at ATS for 90 days

Exclusion Criteria:

  • No access to a computer with Internet capability
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01142609
1RC1DA028189-01, 1RC1DA028189-01
No
Van King, Johns Hopkins University
Johns Hopkins University
National Institute on Drug Abuse (NIDA)
Principal Investigator: Van King, M.D. Johns Hopkins University
Johns Hopkins University
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP